Thu, Apr 17, 2014, 9:11 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Hemispherx Biopharma, Inc. Message Board

  • medicalstarc medicalstarc Jul 17, 2013 2:09 PM Flag

    TBUFF (Mcap $19 M) Price:$0.39 // 7 Marketed Drugs & 1 NDA filing for Potential Blockbuster in 2014 & 1 Pending Approval

    This REAL Unknow and Low Float Gem has already 7 Products on the Market ,1 is Pending Approval and another 1 is close to US-NDA filing for Potential Blockbuster . The Market Cap of $19 M is really a BIG JOKE for a Company which hits $13 Million in revenue last year and growing fast

    Business Includes 7 Marketed Products Including Recently Launched CAMBIA .Tribute sells products in both the primary care and specialty care markets.CAMBIA was launched in October 2012 to compete in the $150 million Canadian migraine market and is expected to be a key contributor to revenue growth in 2013.CAMBIA is a novel, patent-protected, fast-acting, new treatment option for people suffering from acute migraine attacks.Tribute has also entered into a promotional agreement with Pfizer Canada for the exclusive Canadian promotional rights to Gelfoam® in Canada. MycoVa is currently pending regulatory approval in Canada.

    TGT $3-5 within 12 Months ..GLTA

    Tribute Pharma (TBUFF)

    Market Cap : $19 M
    Cash: $3 M
    Price:0.39

    Shares Out : 51 M ( 29 M shares are held by Management alone )

    All these Products below are available on the Market except Bezalip in USA and MycoVa which is pending Approval :

    Product Indication Geographic Right Market Size

    Bezalip® SR Mixed dyslipidemia US & Canada $20 B --- US-NDA filing in 2014

    NeoVisc® Osteoarthritis of the knee Global $1.4 B

    Soriatane® Moderate to severe psoriasis Canada $210 M

    Uracyst® Interstitial cystitis Global $151 M

    CAMBIA® Acute migraine headaches Canada $150 M

    Collatamp G® Prevention of post-operative infection Canada $20 M

    Gelfoam® Hemostatic device Canada $30 M

    MycoVa™ Nail fungus Canada $30 M -- Approval in early 2014

    -.-

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
HEB
0.32-0.01(-1.63%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.